1. Home
  2. BFC vs VIR Comparison

BFC vs VIR Comparison

Compare BFC & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BFC

Bank First Corporation

N/A

Current Price

$149.50

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$11.29

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BFC
VIR
Founded
1894
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
BFC
VIR
Price
$149.50
$11.29
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
★ $163.00
$20.78
AVG Volume (30 Days)
45.7K
★ 1.6M
Earning Date
10-20-2026
11-04-2026
Dividend Yield
★ 1.61%
N/A
EPS Growth
11.23
★ 17.49
EPS
★ 3.99
N/A
Revenue
N/A
★ $68,556,000.00
Revenue This Year
$52.75
$257.66
Revenue Next Year
$29.03
N/A
P/E Ratio
$37.57
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$119.08
$4.82
52 Week High
$159.10
$11.94

Technical Indicators

Market Signals
Indicator
BFC
VIR
Relative Strength Index (RSI) 42.26 56.14
Support Level $147.07 $8.43
Resistance Level $153.72 $11.77
Average True Range (ATR) 2.66 0.51
MACD -0.36 -0.03
Stochastic Oscillator 19.60 59.73

Price Performance

Historical Comparison
BFC
VIR

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: